Trump Goes Scorched Earth on Iran's Supreme Leader
‘Victory Friday’: White House Responds to Victory Over National Injunctions
BREAKING: SCOTUS Rules on Rogue Judges, Impacting Birthright Citizenship
MSNBC Is Melting Down Over the Supreme Court's Birthright Citizenship Ruling
That Is a Brutal Footnote in the Supreme Court's Ruling on Birthright Citizenship
New York City Mayoral Candidate Wants to Raise Taxes – On White People
New York Socialist Zohran Mamdani Uses Martin Luther King Jr. to Push His...
The Supreme Court Just Ruled on This State's Pornography Law
In Kennedy v. Braidwood, SCOTUS Upholds ACA’s Preventive-Care Mandate
More Major Food Companies Embrace the MAHA Movement With Latest Announcements
Gavin Newsom Is Suing Fox News. Here's Why.
So Book Bans Are Okay Now? San Francisco Store Won't Sell JK Rowling's...
Two Leftist Heroes Have Been Ordered Released From Custody
SCOTUS Hands Down Ruling in Landmark Parental Rights Case
Here's the Shocking Reason Why '160 Democrats' Was Just Trending on X
Tipsheet
Premium

Following England’s Lead, Another Country Will Stop Prescribing Puberty Blockers

CHRIS CLARK

Last month, England sent shockwaves around the world when its National Health Service (NHS) announced that children will no longer be prescribed puberty blockers, which Townhall covered. This bold move came after Dr. Hilary Cass, a pediatrician, published a review into the support and treatment offered to children who think they’re born with the wrong gender. She concluded that so-called “gender-affirming” care for kids is built on “shaky foundations.”

Shortly after, the NHS announced it would go a step further and review all transgender treatments for children. Now, another country appears to be following suit. 

Scotland’s lone clinic for “treating” transgender kids announced that it will pause new prescriptions of puberty blockers for children. 

Sandyford, a health clinic in Glasgow operated by Scotland’s National Health Service, made the announcement Thursday (via Sandyford):

Referrals from the Sandyford Sexual Health Services to Paediatric Endocrinology for the prescription of Puberty Suppressing Hormones have been paused for any new patients assessed by our Young Person’s Gender Service.

Patients aged 16 to 17 years old who have not been treated by Paediatric Endocrinology, but who are still seeking treatment for their gender incongruence, will no longer be prescribed gender affirming hormone treatment until they are 18 years old.

[...]

This service update follows research from NHS England and the publication of the Cass Review while we work with the Scottish Government to engage in research with NHS England that will generate evidence of safety and long-term impact for therapies.

In a statement to NBC News, Tracey Gillies, executive medical director at NHS Lothian, one of the 14 regional divisions of NHS Scotland, said that Hilary Cass’ review “is a significant piece of work into how the NHS can better support children and young people who present with gender dysphoria.” 

“Patient safety must always be our priority and it is right that we pause this treatment to allow more research to be carried out,” Gillies added.

Earlier this month, Townhall covered how researchers at the Netherlands’ University of Groningen released a 15-year study, Development of Gender Non-Contentedness During Adolescence and Early Adulthood, that found that most children who feel “transgender” at a young age end up outgrowing it.

In January, Townhall also covered how Sallie Baxendale, professor of clinical neuropsychology at University College London, launched a study into the impacts of puberty blockers on children’s brain functions. Her findings showed that these experimental drugs leave a “detrimental impact” on young children’s IQ levels.

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement